High-Dose Cyclophosphamide, Adriamycin, And Vlncrlstlne (Hd-Cav) In Children with Recurrent Solid Tumor
Authors:
- 1 January 1994
- journal article
- clinical trial
- Published by Taylor & Francis in Pediatric Hematology and Oncology
- Vol. 11 (6) , 613-623
Abstract
A dose-intensive regimen of cyclophosphamide (140 mg/kg over 2 days), doxorubicin (Adriamycin, 75 mg/m2 over 3 days), and vincristine (1 mg/m2 on days 1,2, and 3 and 1.5 mg/m2 on day 9) was tested in 18 children and adolescents with poor-prognosis recurrent or refractory solid tumors. Nine were affected by neuroblastoma, 3 by Ewing's tumors, 2 by rhabdomyosarcoma, 2 by synovial sarcoma, 1 by hepatocellular carcinoma, and 1 by osteogenic sarcoma. All enrolled patients were heavily pretreated, including 2 patients after bone marrow transplantation. Forty courses were applied (median, 2). The overall response rate was 33% (2 complete remissions and 4 partial remissions). Responses were obtained in children with neuroblastoma, Ewing's tumors, and hepatocellular carcinoma. Myelosuppression [World Health Organization (WHO) grade IV after all courses] and cardiac toxicity (3 WHO grade I,5 WHO grade III, and 3 WHO grade IV) were the main side effects. Nephrotoxicity and hepatoxicity were not obserued. With further therapy consisting of surgery, radiotherapy, and high-dose chemotherapy [cisplatin, carboplatin/etoposide (VP16), or ifosfaamide/VP16 with or without autologous stem cell reinfusion after conditioning with melphalan/VP16/carboplatin], 3 complete remissions and 5 very good partial remissions were obtained. Ten of 18 Patients are alive after a median follow-up of 16 months.Keywords
This publication has 8 references indexed in Scilit:
- Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma.Journal of Clinical Oncology, 1993
- The Child with Recurrent Solid TumorPediatric Clinics of North America, 1991
- High-Dose Melphalan, Etoposide ± Carboplatin (Mec) Combined with 12-Gray Fractionated Total-Body Irradiation in Children with Generalized Solid TumorsPediatric Hematology and Oncology, 1991
- Dose-intensive use of cyclophosphamide in ablation of neuroblastomaCancer, 1990
- Autologous Bone Marrow Transplantation in Pediatric Solid TumorsPediatric Hematology and Oncology, 1990
- Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults.Journal of Clinical Oncology, 1987
- High-dose cyclophosphamide (7 g/m2) with or without autologous bone marrow rescue after conventional chemotherapy in the treatment of patients with small cell lung cancerCancer Treatment Reviews, 1983
- Reporting results of cancer treatmentCancer, 1981